Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review

• Main Authors: Kyle Arsenault‐Mehta (Author), Mario Hochman‐Bérard (Author), Alexander Johnson (Author), Dar'ya Semenova (Author), Bea Nguyen (Author), Jessie Willis (Author), Natalia Mouravska (Author), Ridha Joober (Author), Naista Zhand (Author)
• Format: Book
• Published: Wiley, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Cognitive impairment are among the core features of schizophrenia, experienced by up to 75% of patients. Available treatment options for schizophrenia including dopamine antagonists and traditional antipsychotic medications have not been shown to confer significant benefits on co...